Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Hemoglobin A1c test is a common blood test performed for diagnosis and monitoring of type 1 and type 2 diabetes. A1c test results reflect the average blood sugar levels of an individual for the past two to three months. Hemoglobin (Hb) is a protein that links with sugars such as glucose found inside red blood cells. High amount of glucose linked (glycated) with hemoglobin molecules increases the risk of diabetes. HbA1c test reports the amount of HbA1c as a proportion of total hemoglobin in the blood stream.

Statistics:

The global hemoglobin A1c testing devices market is estimated to account for US$ 4,129.4 Mn in terms of value by the end of 2027.

Global Hemoglobin A1c Testing Devices Market: Drivers

Increasing prevalence of diabetes is expected to propel growth of the global hemoglobin A1c testing devices market over the forecast period. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.

Moreover, increasing geriatric population is also expected to aid in growth of the market. For according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.         

Statistics:

North America held dominant position in the global hemoglobin A1c testing devices market in 2019, accounting for 36.8% share in terms of value, followed by Europe and Asia Pacific, respectively

Figure 1: Global Hemoglobin A1c Testing Devices Market Share (%) Value, By Region, 2019

Hemoglobin A1c Testing Devices  | Coherent Market Insights

Global Hemoglobin A1c Testing Devices Market: Restraints

High test cost is expected to hinder growth of the global hemoglobin A1c testing devices market. Laboratory testing of hemoglobin A1c is a costly and time consuming affair, which restricts patients from seeking A1C testing. Even healthcare practitioners prefer blood glucose testing in case of emergencies.

Moreover, low adoption of hemoglobin A1c testing in emerging economies is also expected to aid in growth of the market. This is due to the lack of awareness and acceptance of hemoglobin A1c testing method by the healthcare fraternity and general population. One of the reasons for low acceptance of these solutions is the high cost compared to conventional blood glucose testing.

Global Hemoglobin A1c Testing Devices Market: Opportunities

High prevalence of undiagnosed diabetes in emerging economies is expected to offer lucrative growth opportunities for players in the market. For instance, according to the study, ‘The Economic Burden of Elevated Blood Glucose Levels in 2017: Diagnosed and Undiagnosed Diabetes, Gestational Diabetes, and Prediabetes’, published in the journal Diabetes Care, in April 2019, the economic burden associated with diagnosed diabetes, undiagnosed diabetes, prediabetes (adults), and gestational diabetes (mothers and newborns) reached US$ 327.2 billion, US$ 31.7 billion, US$ 43.4 billion for prediabetes, and US$ 1.6 billion for gestational diabetes, respectively, in 2017, in the U.S. 

Moreover, introducing cost-effective HbA1c tests and devices is also expected to aid in growth of the market.

Statistics:

The global hemoglobin A1c testing devices market was valued at US$ 1,863.7 Mn in 2019 and is forecast to reach a value of US$ 4,129.4 Mn by 2027 at a CAGR of 10.5% between 2020 and 2027.

Figure 2: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn), 2016 - 2027

Hemoglobin A1c Testing Devices  | Coherent Market Insights

Market Trends/Key Takeaways

The current trend is shifting towards the Clinical Laboratory Improvement Amendments (CLIA) waived tests and hence manufacturing CLIA waived tests will bolster the demand for CLIA waived HbA1c testing devices. Moreover, introduction of CLIA waived POC HbA1c testing devices will increase the market demand for POC devices and thus in turn will be beneficial for both manufacturers as well as customers.

Several studies have demonstrated higher efficacy of glucose tolerance test over hemoglobin A1c blood test. For instance, in March 2019, a study by City of Hope Diabetes and Metabolism Research Institute, published at the Endocrine Society’s ENDO 2019, reported that hemoglobin A1c blood test missed almost 73% of the people with diabetes in comparison to the oral glucose tolerance test.

Global Hemoglobin A1c Testing Devices Market: Competitive Landscape

Major players operating in the global hemoglobin A1c testing devices market include, Abbott Laboratories, ARKRAY, Inc., Bio-Rad Laboratories, Inc., Chek Diagnostics (Polymer Technology Systems, Inc.), Danaher Corporation (Beckman Coulter),  F. Hoffmann-La Roche Ltd., Menarini Group, Sebia, Siemens Healthcare, Tosoh Corporation, and Trinity Biotech plc.

Global Hemoglobin A1c Testing Devices Market: Key Developments

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in June 2019, Abbott Laboratories launched Afinion HbA1c Dx test, a 3-minute, in-office A1c blood test for diagnosing diabetes.

Similarly, in May 2019, Siemens Healthineers launched its new Atellica CH Enzymatic Hemoglobin A1c Assay to for diagnosing and monitoring diabetes.

Hemoglobin A1c Testing Devices are used for diagnosis and monitoring of type 1 and type 2 diabetes. Hemoglobin A1c test results reflect the average blood sugar levels of an individual for the past two to three months. Increasing prevalence of diabetes is expected to propel growth of the global hemoglobin A1c testing devices market over the forecast period.

Furthermore, increasing geriatric population, increasing healthcare infrastructure, and high prevalence of undiagnosed diabetes in emerging economies is also expected to propel the market growth during the forecasted period.

Key features of the study:

  • This report provides in-depth analysis of the Hemoglobin A1c Testing Devices market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global Hemoglobin A1c Testing Devices market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Abbott Laboratories, ARKRAY, Inc., Bio-Rad Laboratories, Inc., Chek Diagnostics (Polymer Technology Systems, Inc.), Danaher Corporation (Beckman Coulter), Hoffmann-La Roche Ltd., Menarini Group, Sebia, Siemens Healthcare, Tosoh Corporation, and Trinity Biotech plc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Hemoglobin A1c Testing Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Hemoglobin A1c Testing Devices market

Detailed Segmentation:

  • Hemoglobin A1c Testing Devices Market, By Test Type:
    • Laboratory Testing Devices
    • Point-of-care Testing Devices
  • Hemoglobin A1c Testing Devices Market, By Technology:
    • Ion-Exchange HPLC
    • Immunoassay
    • Boronate Affinity Chromatography
    • Direct Enzymatic Assay
    • Others
  • Hemoglobin A1c Testing Devices Market, By Region:
    • North America
      • By Test Type:
        • Laboratory Testing Devices
        • Point-of-care Testing Devices
      • By Technology
        • Ion-Exchange HPLC
        • Immunoassay
        • Boronate Affinity Chromatography
        • Direct Enzymatic Assay
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Test Type:
        • Laboratory Testing Devices
        • Point-of-care Testing Devices
      • By Technology
        • Ion-Exchange HPLC
        • Immunoassay
        • Boronate Affinity Chromatography
        • Direct Enzymatic Assay
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Test Type:
        • Laboratory Testing Devices
        • Point-of-care Testing Devices
      • By Technology
        • Ion-Exchange HPLC
        • Immunoassay
        • Boronate Affinity Chromatography
        • Direct Enzymatic Assay
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Test Type:
        • Laboratory Testing Devices
        • Point-of-care Testing Devices
      • By Technology
        • Ion-Exchange HPLC
        • Immunoassay
        • Boronate Affinity Chromatography
        • Direct Enzymatic Assay
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Test Type:
        • Laboratory Testing Devices
        • Point-of-care Testing Devices
      • By Technology
        • Ion-Exchange HPLC
        • Immunoassay
        • Boronate Affinity Chromatography
        • Direct Enzymatic Assay
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Test Type:
        • Laboratory Testing Devices
        • Point-of-care Testing Devices
      • By Technology
        • Ion-Exchange HPLC
        • Immunoassay
        • Boronate Affinity Chromatography
        • Direct Enzymatic Assay
        • Others
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Abbott Laboratories*
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • ARKRAY, Inc.
    • Bio-Rad Laboratories, Inc.
    • Chek Diagnostics (Polymer Technology Systems, Inc.)
    • Danaher Corporation (Beckman Coulter)
    • F. Hoffmann-La Roche Ltd.
    • Menarini Group
    • Sebia
    • Siemens Healthcare
    • Tosoh Corporation
    • Trinity Biotech plc.
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Test Type
      • Market Snippet, By Technology
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Technological Advancements
    • Regulatory Scenario
    • Mergers and Acquisitions
  4. Hemoglobin A1c Testing Devices Market, By Test Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Laboratory Testing Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Point-of-care Testing Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Hemoglobin A1c Testing Devices Market, By Technology, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Ion-Exchange HPLC
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Immunoassay
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Boronate Affinity Chromatography
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Direct Enzymatic Assay
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Hemoglobin A1c Testing Devices Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  7. Competitive Landscape
    • Company Profiles
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • ARKRAY, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Chek Diagnostics (Polymer Technology Systems, Inc.)
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Danaher Corporation (Beckman Coulter)
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • F. Hoffmann-La Roche Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Menarini Group
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sebia
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Siemens Healthcare
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Tosoh Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Trinity Biotech plc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 20 market data tables and 12 figures on “Hemoglobin A1c Testing Devices Market - Global forecast to 2027”.

Frequently Asked Questions

The global Hemoglobin A1c Testing Devices market size was valued at US$ 1,863.7 million in 2019 and is estimated to exhibit a CAGR of 10.5% between 2020 and 2027.
Laboratory Testing Devices in Test Type segment held the major market share in 2019 owing to an increasing prevalence of diabetes during the forecast period.
Major factor driving the growth of global Hemoglobin A1c Testing Devices market during the forecast period increasing prevalence of diabetes, increasing research and development, along with increasing healthcare expenditure in developing economies.
Low adoption of hemoglobin A1c testing in emerging economies is expected to limit growth of the market during the forecast period
North America Hemoglobin A1c Testing Devices market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Abbott Laboratories, ARKRAY, Inc., Bio-Rad Laboratories, Inc., Chek Diagnostics (Polymer Technology Systems, Inc.), Danaher Corporation (Beckman Coulter), F. Hoffmann-La Roche Ltd., Menarini Group, Sebia, Siemens Healthcare, Tosoh Corporation, and Trinity Biotech plc.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner